Waldenstrom's Macroglobulinemia Program Dana-Farber Cancer Institute
  Publications
  Media
 
 
  Email this page to a friend >

 

   
  Soluble CD27 Is a Faithful Marker of Disease Burden and Is Unaffected by the Rituximab-Induced IgM Flare, as Well as by Plasmapheresis, in Patients with Waldenström's Macroglobulinemia.
3/18/2009
By B Ciccarelli, G Yang, E Hatjiharissi, L Ioakimidis, C Patterson, R Manning, L Xu, X Liu, H Tseng, P Gong, J Sun, Y Zhou, SP Treon
Publisher: Clinical Lymphoma & Myeloma

Please refer to attachment.
View Attachment


<< Back